Fluoxetine versus N-acetylcysteine in reducing craving in Indian men with alcohol dependence syndrome: a randomised controlled trial
East Asian Archives of Psychiatry · 2025
DOI: 10.12809/eaap2591 ↗At a glance
Randomisierte kontrollierte Studie in East Asian Archives of Psychiatry, 2025. Written by T Shruthi and 2 co-authors. Institution: Department of Psychiatry, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, India. Major MEDLINE topics: Acetylcysteine, Craving, Alcoholism, Fluoxetine. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
OBJECTIVES: To compare the efficacy of fluoxetine and N-acetylcysteine (NAC) in reducing craving, relapse, and improving treatment adherence in men with alcohol dependence syndrome (ADS). METHODS: Men aged 18 to 65 years with a diagnosis of ADS who had maintained ≥7 days of abstinence from alcohol were recruited. Participants were randomised in a 1:1 ratio to receive either oral fluoxetine 20 mg/day or NAC 600 mg twice/day for 12 weeks. Participants were followed up at weeks 4, 8, and 12. Outcome measures included the Penn Alcohol Craving Scale (PACS), relapse rate, treatment adherence, and adverse effects. RESULTS: In total, 100 men were equally randomised to receive either fluoxetine or NAC. Both fluoxetine and NAC were effective in lowering PACS scores over 12 weeks, with scores being lower in the NAC group than in the fluoxetine group at week 4 (15.4 vs 17.6, p = 0.03), week 8 (11.3 vs 14.2, p = 0.002), and week 12 (7.8 vs 11.1, p < 0.001). The reduction in PACS scores was significantly greater in the NAC group from week 4 onward. Relapse rates were lower in the NAC group (18.0% vs 32.0%, p = 0.049). Treatment adherence was higher (but not significantly) in the NAC group (90.0% vs 84.0%, p = 0.38). Both medications were well tolerated. All adverse effects were mild. CONCLUSION: Both fluoxetine and NAC were effective in reducing alcohol craving over 12 weeks, with greater reduction in the NAC group at each follow-up assessment. The NAC group also had a lower relapse rate and better adherence and tolerability.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Psychiatry, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, India.
Cite
APA
Shruthi, T., Govindan, L., & Kanagarajan, S. S. (2025). Fluoxetine versus N-acetylcysteine in reducing craving in Indian men with alcohol dependence syndrome: a randomised controlled trial. East Asian Archives of Psychiatry. https://doi.org/10.12809/eaap2591
Vancouver
Shruthi T, Govindan L, Kanagarajan SS. Fluoxetine versus N-acetylcysteine in reducing craving in Indian men with alcohol dependence syndrome: a randomised controlled trial. East Asian Archives of Psychiatry. 2025. doi:10.12809/eaap2591
BibTeX
@article{Shruthi2025,
author = {Shruthi, T and Govindan, L and Kanagarajan, S S},
title = {Fluoxetine versus N-acetylcysteine in reducing craving in Indian men with alcohol dependence syndrome: a randomised controlled trial},
journal = {East Asian Archives of Psychiatry},
year = {2025},
doi = {10.12809/eaap2591}
}
EUVIMED